DAM have been characterized for the first time in 5xFAD mice (Keren-Shaul et al., 2017), a transgenic AD mouse model that expresses five human familial AD-linked mutations in the APP and PSEN1 genes (Oakley et al., 2006). This evidence concerns the gene APP and Alzheimer disease.